AACE
<ѻý class="page-description">American Association of Clinical Endocrinologyѻý>Disparities in outcomes, healthcare use for type 2 versus type 1 disease
Pilot program cut HbA1c, boosted functional mobility, and fostered camaraderie
But meta-analysis indicates incidence of autoimmune disorders highest after first dose
It can take 20 weeks to titrate to highest dose, researcher points out
Both younger and older patients had similar overall improvements
Beta-hydroxybutyrate-based stopping point reduced burden on patients
Helped diabetics cut down on daily insulin dose, body weight
But drug remains in regulatory limbo
Waist-to-hip-ratio, waist circumference can aid in predicting IR, researcher says
Significant reductions in heart-harming inflammatory cytokines also noted
Diabetic nephropathy was most common of the fatal complications, study showed
More than half of patients saw physical manifestations fully resolve by week 72
Trial followed patients with Senza System for 18 months
Using the system only in auto-mode still achieved a 1.5% drop in HbA1c
-
Obesity Week: The Obesity Society
November 2024
-
EASD: European Association for the Study of Diabetes
September 2024
-
ENDO: The Endocrine Society
June 2024
-
AACE: American Association of Clinical Endocrinology
May 2024